These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 26486566

  • 1. Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis.
    Hung AW, Silvestre HL, Wen S, George GP, Boland J, Blundell TL, Ciulli A, Abell C.
    ChemMedChem; 2016 Jan 05; 11(1):38-42. PubMed ID: 26486566
    [Abstract] [Full Text] [Related]

  • 2. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y, Gao P, Liu Y, Ji X, Gan M, Guan Y, Hao X, Li Z, Xiao C.
    Bioorg Med Chem Lett; 2011 Jul 01; 21(13):3943-6. PubMed ID: 21641210
    [Abstract] [Full Text] [Related]

  • 3. Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
    Samala G, Devi PB, Nallangi R, Sridevi JP, Saxena S, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1938-47. PubMed ID: 24565972
    [Abstract] [Full Text] [Related]

  • 4. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.
    Velaparthi S, Brunsteiner M, Uddin R, Wan B, Franzblau SG, Petukhov PA.
    J Med Chem; 2008 Apr 10; 51(7):1999-2002. PubMed ID: 18335974
    [Abstract] [Full Text] [Related]

  • 5. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2014 Aug 01; 22(15):4223-32. PubMed ID: 24953948
    [Abstract] [Full Text] [Related]

  • 6. Optimization of the interligand Overhauser effect for fragment linking: application to inhibitor discovery against Mycobacterium tuberculosis pantothenate synthetase.
    Sledz P, Silvestre HL, Hung AW, Ciulli A, Blundell TL, Abell C.
    J Am Chem Soc; 2010 Apr 07; 132(13):4544-5. PubMed ID: 20232910
    [Abstract] [Full Text] [Related]

  • 7. Application of fragment growing and fragment linking to the discovery of inhibitors of Mycobacterium tuberculosis pantothenate synthetase.
    Hung AW, Silvestre HL, Wen S, Ciulli A, Blundell TL, Abell C.
    Angew Chem Int Ed Engl; 2009 Apr 07; 48(45):8452-6. PubMed ID: 19780086
    [No Abstract] [Full Text] [Related]

  • 8. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
    Devi PB, Jogula S, Reddy AP, Saxena S, Sridevi JP, Sriram D, Yogeeswari P.
    Mol Inform; 2015 Feb 07; 34(2-3):147-59. PubMed ID: 27490037
    [Abstract] [Full Text] [Related]

  • 9. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Devi PB, Samala G, Sridevi JP, Saxena S, Alvala M, Salina EG, Sriram D, Yogeeswari P.
    ChemMedChem; 2014 Nov 07; 9(11):2538-47. PubMed ID: 25155986
    [Abstract] [Full Text] [Related]

  • 10. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Devi PB, Nallangi R, Yogeeswari P, Sriram D.
    Eur J Med Chem; 2013 Nov 07; 69():356-64. PubMed ID: 24077526
    [Abstract] [Full Text] [Related]

  • 11. Integrated biophysical approach to fragment screening and validation for fragment-based lead discovery.
    Silvestre HL, Blundell TL, Abell C, Ciulli A.
    Proc Natl Acad Sci U S A; 2013 Aug 06; 110(32):12984-9. PubMed ID: 23872845
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of Mycobacterium tuberculosis pantothenate synthetase by analogues of the reaction intermediate.
    Ciulli A, Scott DE, Ando M, Reyes F, Saldanha SA, Tuck KL, Chirgadze DY, Blundell TL, Abell C.
    Chembiochem; 2008 Nov 03; 9(16):2606-11. PubMed ID: 18821554
    [No Abstract] [Full Text] [Related]

  • 13. Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation.
    Suryadevara P, Yogeeswari P, Soni V, Devi PB, Nandicoori VK, Sriram D.
    Curr Top Med Chem; 2016 Nov 03; 16(9):978-95. PubMed ID: 26303425
    [Abstract] [Full Text] [Related]

  • 14. Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA.
    Prati F, Zuccotto F, Fletcher D, Convery MA, Fernandez-Menendez R, Bates R, Encinas L, Zeng J, Chung CW, De Dios Anton P, Mendoza-Losana A, Mackenzie C, Green SR, Huggett M, Barros D, Wyatt PG, Ray PC.
    ChemMedChem; 2018 Apr 06; 13(7):672-677. PubMed ID: 29399991
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G, Devi PB, Saxena S, Meda N, Yogeeswari P, Sriram D.
    Bioorg Med Chem; 2016 Mar 15; 24(6):1298-307. PubMed ID: 26867485
    [Abstract] [Full Text] [Related]

  • 16. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
    Doğan H, Doğan ŞD, Gündüz MG, Krishna VS, Lherbet C, Sriram D, Şahin O, Sarıpınar E.
    Eur J Med Chem; 2020 Feb 15; 188():112035. PubMed ID: 31951850
    [Abstract] [Full Text] [Related]

  • 17. Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosis glutamine synthetase.
    Kosikowska P, Bochno M, Macegoniuk K, Forlani G, Kafarski P, Berlicki Ł.
    J Enzyme Inhib Med Chem; 2016 Dec 15; 31(6):931-8. PubMed ID: 26235917
    [Abstract] [Full Text] [Related]

  • 18. The Mur Enzymes Chink in the Armour of Mycobacterium tuberculosis cell wall.
    Shinde Y, Ahmad I, Surana S, Patel H.
    Eur J Med Chem; 2021 Oct 15; 222():113568. PubMed ID: 34118719
    [Abstract] [Full Text] [Related]

  • 19. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
    Chiarelli LR, Mori M, Barlocco D, Beretta G, Gelain A, Pini E, Porcino M, Mori G, Stelitano G, Costantino L, Lapillo M, Bonanni D, Poli G, Tuccinardi T, Villa S, Meneghetti F.
    Eur J Med Chem; 2018 Jul 15; 155():754-763. PubMed ID: 29940465
    [Abstract] [Full Text] [Related]

  • 20. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M, Szadocka S, Degiacomi G, Orena BS, Mori G, Piano V, Boldrin F, Zemanová J, Huszár S, Barros D, Ekins S, Lelièvre J, Manganelli R, Mattevi A, Pasca MR, Riccardi G, Ballell L, Mikušová K, Chiarelli LR.
    ACS Infect Dis; 2017 Jun 09; 3(6):428-437. PubMed ID: 28475832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.